Title : Raltegravir: in treatment-naive patients with HIV-1 infection.

Pub. Date : 2010 Mar 26

PMID : 20329808






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The efficacy of raltegravir in achieving HIV-1 RNA levels of <50 copies/mL was also demonstrated in subgroups of patients separated according to baseline viral levels, CD4+ cell counts and viral subtypes. Raltegravir Potassium CD4 molecule Homo sapiens
2 Preliminary evidence suggests that both virological and CD4+ cell count improvements were maintained at 96 weeks for treatment-naive recipients of raltegravir 400 mg twice daily. Raltegravir Potassium CD4 molecule Homo sapiens